pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-452 |
Genomic Coordinates | chrX: 151959628 - 151959712 |
Synonyms | MIRN452, hsa-mir-452, MIR452 |
Description | Homo sapiens miR-452 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-452-3p | ||||||||||||||||||
Sequence | 58| CUCAUCUGCAAAGAAGUAAGUG |79 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Array-cloned | ||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SUB1 | ||||||||||||||||||||
Synonyms | P15, PC4, p14 | ||||||||||||||||||||
Description | SUB1 homolog, transcriptional regulator | ||||||||||||||||||||
Transcript | NM_006713 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SUB1 | |||||||||||||||||||||
3'UTR of SUB1 (miRNA target sites are highlighted) |
>SUB1|NM_006713|3'UTR 1 AATTCGAGCCATATAAATAAAACCTGTACTGTTCTAGTTGTTTTAATCTGTCTTTTTACATTGGCTTTTGTTTTCTAAAT 81 GTTCTCCAAGCTATTGTATGTTTGGATTGCAGAAGAATTTGTAAGATGAATACTTTTTTTTAATGTGCATTATTAAAAAT 161 ATTGAGTGAAGCTAATTGTCAACTTTATTAAGGATTACTTTGTCTGCCCACCACCTAGTGTAAAATAAAATCAAGTAATA 241 CAATCTTAACTGTTGTGGCCTTTTTTGATCATAAGAGTTGGTACTGTTTAAGGCCAAAAGTAACAGTTTTTATAGATCTT 321 TTAGTTTCAACTCAGCTTTTACAATAAAAAGGATTTGTATTGCATTGAGTTTATAAACTTTTGGTTTGTGAACTTCATAT 401 TTGATCTTTTCTCTTCCAATCAAATGTCTAGGCTTGTTTGACTTCCACCCCCAATGGTTTTTCACTCTTTTTATTTACTT 481 CATTTTCCTTTAATAACTTAATCTCTTCATGTTCAGTTTTTACTTCACTCTTTATTCTTTTCTTTGATTATGGTATGCTT 561 ATTTGGAAAGTCAGTGAAACTGTCAAAATGTTATCTCAATAAGATACTTATATGAGAACTACAATCACCGAATCTACTGT 641 ATTCAATATTAGCAGATCTAATTTGATAAACAACATGGCTTGTGTGAAAACTGAGCAGGTGTTTGTTTACCCATAGTGTT 721 CTGTGTAGTTATTGCTTAGTCTGCAGAAAATAATGACTTAGATGAGATGTCTGACTTGCTTTCACTTATTAAACATGTTC 801 ACCATGGGATGATGTCTGTAACATCAGATATTGTTCAACTAGACTAGGATTTAATAAAAATTGTGAAAGCTTACTGGCCT 881 AACATTTTATTTTATAATATTGGGTATGAATTATATGTAGCCAGAGATGTCATTAAGCTTTACTGTTATAGTAGGTAATA 961 TGGTTAGTTTGTAGGGAAAAGAGCATATGAGCACATGCTTGTGTATTTTGGCCTTTGCCCCAGTAGAACAGACCAATGGC 1041 ATTCTAGACTTGATGATACTAAGTTTTAGCAGACACTAGTAAGTGGTTTGTATTTAACCATACTGATGAAGCAGACAGAT 1121 TGAGGCACAGATTTTAGTGGCTTTGTGGCAATAAATAGGGCATGGTGTGCCTTAGGAAAAGAATGTTTATAAAGGGAATT 1201 ATAACTGAAATTAAAGGAGGCGGCAGTGAAGAGGAAATAATTCTCTTCTATCTAAATGATATACATATGATATTTTGAGA 1281 TTTTTATAACAGCAGTGGAACACAATTCTAGGTAGAGTAGAAAAAGGAAAGTTTTAAAGACATATAAAAGATTCTTGTTG 1361 ACAAATTATTTTTGGTAGCAAATCTCAAATGGTTACCTGCTATTAAGGTCTGCCATATTAGAGTTTTGCACTATTTTGCT 1441 ACCAAGTTTGATTCATACATCTAAAACATTTTGTAGTTACTTGTCAAGGACTTAATTTGAAAATCATTTGCCAGGCCACA 1521 TAGTTATCAATTTTTTTTTCTATCAGCTATTCTGTTGTATTTCTAAAACATTTTTTAGATGACTTTTTAAAGTATATTTA 1601 GCAGTAACCTTATGAGGTTCAAATTGGTAAATCTCTTGTAATTTAGCCTTCATCGAATAATAGGTACCAGTGTATTAAAA 1681 ATGTGTATTTTTTGCAGCCCCTTGAACCAGAGTAGGTTCAGAGAAACTCCCAAAGTTTGTACTTTAGACACATCATGCTT 1761 GATTGGTAACTTCCCTCCTTTTTTGGGGAACATGTTTGTGTCCTATTAACTTAATTGGATAGATTTTTAAATATTTCTTA 1841 TTTTTGGCACACGGAAAGGGTAGTTCGAGTACAGAACTTTGATTTTTGGTGTAGATGCAGAGGGAATGATGGGTAAATTT 1921 CCTAGGTTTATGTGAATTTAGGGGGTGTATGCATTTTGAAACAATCTACTAACAGATGGTGCTGAAATCTATTACCTACA 2001 TGTTTTCTAGTTGTTCAGCATTATGTTAATGAAGCCTCCATATAAGGAGTGTTTCTCTGGCACAGTTGGTAAGTTGACTG 2081 CTAACTTCATTTAAATGTGTTACTGGATATGCAGTATACTGAAATTATTAATCAGTTTGTGTATAGGAAAAGAGAACTGG 2161 GTTAAAAGCAAATTAACTTGTTCTGAAAAGAAAGTATAGATTAATTTTGTTTTCTGTTTAAATTTTATCTCCTTGGTAAA 2241 GATTTTTTTTTCCTGGGCAGAAAACTTGGCATTTTTAGGCGTAGATACCTTACCTTACAATGCCAAAATGAATTTAATTC 2321 CAGTACTCAGGTTTTTCCCTTTAACAGACTCTATGTGTATCAGGGCTTTCTAATGGGTTTTTCCTCTTCGTTTTTAAAAT 2401 GTGAGTAGCATTTGACCAATTTCCAGTGCTCTTAGCATTTTACTTAAAGAACAACCACTACAAAAGAAAATCTTTGTAAT 2481 TTGATTGTCTTTTGCTTTGCTTCATTAATGCCTAAGAACTTAAGAATACTCCTACCTCATTAGCTACTCAAGATGCTGTG 2561 ACGATCAAATCTATTCTACATAATGCGTTTAGAAACAAAGACTTGGGTGAAAAATGAAATAAGTATATTCTGACTTGGCT 2641 ATTGAGGGGAAAATTCAGTATTAAGTGTTCCTCACAGGAGATATGTTAGCAGAATACTATAAAAGTTTGAAATTTTTAAA 2721 AAGTAAAAGTACTTAAATTTAGGTATCTCTCCTGAAATTCTTTGCAGTTCATTTTTTATGGCAGTTAATCCAGTGAAACA 2801 CTCAAAAGTTTTTTTTTTTTTAAAAGTGTTTTTCCAGATAAACTGTAGGGTGAACATTCACATAATCACAAATATGTAAT 2881 TCTGTAATTGTGGAATGCTTGTATGCTTTGTTTTCGTACATCTTCCATGGAGATGTCTGAATATAATACTCCATCTGTGA 2961 ATATTTTAAATGTTGAAATAAAAGTAAGAAATGTGAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 10923.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 10923.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000265073.4 | 3UTR | AAUACUUUUUUUUAAUGUGCAUUAUUAAAAAUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000265073.4 | 3UTR | UAAGAUGAAUACUUUUUUUUAAUGUGCAUUAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
87 hsa-miR-452-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT150000 | MIDN | midnolin | ![]() |
![]() |
2 | 10 | ||||||
MIRT330600 | ZWINT | ZW10 interacting kinetochore protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT358701 | SUB1 | SUB1 homolog, transcriptional regulator | ![]() |
![]() |
2 | 4 | ||||||
MIRT362854 | EIF4H | eukaryotic translation initiation factor 4H | ![]() |
![]() |
2 | 2 | ||||||
MIRT447215 | ATXN7 | ataxin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466655 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | ![]() |
![]() |
2 | 6 | ||||||
MIRT483979 | PANK1 | pantothenate kinase 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT485118 | SF3B3 | splicing factor 3b subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488864 | AUTS8 | Autism, susceptibility to, 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492293 | SH2B3 | SH2B adaptor protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492976 | NCK2 | NCK adaptor protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497410 | LRRC40 | leucine rich repeat containing 40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT511143 | MRPL17 | mitochondrial ribosomal protein L17 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512650 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT513017 | NSFL1C | NSFL1 cofactor | ![]() |
![]() |
2 | 6 | ||||||
MIRT520445 | TSPAN2 | tetraspanin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT527995 | NDNF | neuron derived neurotrophic factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT528667 | PDE4DIP | phosphodiesterase 4D interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT533512 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537404 | FBXO47 | F-box protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538161 | DCP2 | decapping mRNA 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT539124 | ARHGEF17 | Rho guanine nucleotide exchange factor 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540666 | MIS18A | MIS18 kinetochore protein A | ![]() |
![]() |
2 | 4 | ||||||
MIRT542948 | GDF11 | growth differentiation factor 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547534 | MAML3 | mastermind like transcriptional coactivator 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559033 | C20orf24 | chromosome 20 open reading frame 24 | ![]() |
![]() |
2 | 4 | ||||||
MIRT559554 | ARF6 | ADP ribosylation factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570177 | RCBTB1 | RCC1 and BTB domain containing protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573149 | ITGA9 | integrin subunit alpha 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575849 | Rab1 | RAB1A, member RAS oncogene family | ![]() |
1 | 1 | |||||||
MIRT611034 | RRP1B | ribosomal RNA processing 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT616281 | HMGB1 | high mobility group box 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618372 | PRKG2 | protein kinase, cGMP-dependent, type II | ![]() |
![]() |
2 | 2 | ||||||
MIRT619540 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622303 | SGIP1 | SH3 domain GRB2 like endophilin interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622590 | PRRG4 | proline rich and Gla domain 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624441 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637089 | KLRD1 | killer cell lectin like receptor D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639084 | ADCYAP1 | adenylate cyclase activating polypeptide 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639334 | NINJ1 | ninjurin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT639798 | EIF3E | eukaryotic translation initiation factor 3 subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT640851 | RAB3B | RAB3B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT641628 | KIAA1244 | ARFGEF family member 3 | ![]() |
1 | 1 | |||||||
MIRT642634 | EPPIN | epididymal peptidase inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT643053 | EPPIN-WFDC6 | EPPIN-WFDC6 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT643416 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | ![]() |
![]() |
2 | 2 | ||||||
MIRT645586 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT647393 | FAM181B | family with sequence similarity 181 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT649411 | CDC14B | cell division cycle 14B | ![]() |
![]() |
2 | 2 | ||||||
MIRT649477 | CLDN16 | claudin 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651307 | ZDHHC20 | zinc finger DHHC-type containing 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651387 | ZBTB16 | zinc finger and BTB domain containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT653411 | SLC7A2 | solute carrier family 7 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654084 | RSPH4A | radial spoke head 4 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT654613 | PTPRM | protein tyrosine phosphatase, receptor type M | ![]() |
![]() |
2 | 2 | ||||||
MIRT655338 | PCP4L1 | Purkinje cell protein 4 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656173 | MRPL44 | mitochondrial ribosomal protein L44 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657272 | HS3ST3B1 | heparan sulfate-glucosamine 3-sulfotransferase 3B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657881 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659875 | CAPRIN1 | cell cycle associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662381 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT666308 | SLC22A3 | solute carrier family 22 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667274 | NAV1 | neuron navigator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667614 | LIMCH1 | LIM and calponin homology domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674242 | NUP62 | nucleoporin 62 | ![]() |
![]() |
2 | 4 | ||||||
MIRT690386 | PARP15 | poly(ADP-ribose) polymerase family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693402 | NUDT16 | nudix hydrolase 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702503 | KDELR1 | KDEL endoplasmic reticulum protein retention receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708632 | STMN4 | stathmin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708839 | SCAND3 | zinc finger BED-type containing 9 | ![]() |
1 | 1 | |||||||
MIRT709016 | HSBP1 | heat shock factor binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709235 | RANGAP1 | Ran GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710885 | PARL | presenilin associated rhomboid like | ![]() |
![]() |
2 | 2 | ||||||
MIRT712262 | PPP1CB | protein phosphatase 1 catalytic subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT712573 | ATP2B4 | ATPase plasma membrane Ca2+ transporting 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715046 | PRPF38A | pre-mRNA processing factor 38A | ![]() |
![]() |
2 | 2 | ||||||
MIRT718905 | GALR1 | galanin receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719368 | FEM1A | fem-1 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT719495 | SEC24B | SEC24 homolog B, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT719601 | PRKX | protein kinase, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT719891 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720063 | ZNF449 | zinc finger protein 449 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721679 | CMTM4 | CKLF like MARVEL transmembrane domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721724 | VTI1A | vesicle transport through interaction with t-SNAREs 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT723370 | ZNF470 | zinc finger protein 470 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724941 | TXNL1 | thioredoxin like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725302 | NLRC5 | NLR family CARD domain containing 5 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|